Member access

4-Traders Homepage  >  Shares  >  Stock Exchange of Hong Kong  >  Lansen Pharmaceutical Holdings Co., Ltd.    0503   KYG5380M1033

End-of-day quote. End-of-day quote Stock Exchange of Hong Kong - 09/01
3.83 HKD   +13.65%
4d ago LANSEN PHARMACEUTICAL : Pharma 1H net up 14.5% to US$7.3m; div HK9.54 cts
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes Western pharmaceuticals

Lansen Pharmaceutical Holdings Ltd. is an investment holding company, which operates through its subsidiaries engages in the manufacturing and trading of pharmaceutical products.

It operates through two segments: Rheumatic Specialty Prescription Western Pharmaceuticals and Other Pharmaceuticals.

The Specialty Prescription Western Pharmaceuticals segment products include pafulin, liupuan, yisuojia and tuoshu.

The Other Pharmaceuticals segment provides indometacin cataplasm, bazhen keli, yinxingye pian, paracetamol orally and disintegrating tablets.

The company was founded on September 10, 2009 and is headquartered in Ningbo, China.

Number of employees : 850 persons.
Sales per Regions
20122013Delta
HKD (in Million)%HKD (in Million)%
China90.1712.4%89.7512.2% -0.46%
Rest of the World3.690.5%5.330.7% +30.82%
Managers
NameAgeSinceTitle
Lei Yung Poon, MBA48-Senior Vice President
Yi Liang49-Chief Technology Officer
Rong Zhou44-Senior Vice President
Xin Ming Zhang40-Chief OTC Business Officer
Stephen Burnau Hunt742010Chairman
Jin-Yi Lee, MBA562010Deputy Chairman
Jun Tang542010Non-Executive Director
Fang Fang Tao432010Non-Executive Director
Pui Ling Yip552009Non-Executive Director
Kee Huen Chan62-Independent Non-Executive Director
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances
Profitability
Earnings quality
Business Predictability -
PER -
Potential -
Yield
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
OTSUKA HOLDINGS C..
ASPEN PHARMACARE ..
BIOMARIN PHARMACE..
ONO PHARMACEUTICA..
ENDO INTERNATIONA..
HOSPIRA, INC.
SHANGHAI FOSUN PH..
SIHUAN PHARMACEUT..
CIPLA LTD
TAISHO PHARMACEUT..
CADILA HEALTHCARE..
XIZANG HAISCO PHA..
LUYE PHARMA GROUP..
-
CHINA MEDICAL SYS..
DIVI'S LABORATORI..
SHENZHEN SALUBRIS..
SICHUAN KELUN PHA..
-
GLENMARK PHARMACE..
RICHTER GEDEON VE..
Sector Pharmaceuticals
Company contact information
Lansen Pharmaceutical Holdings Ltd.
Building 14, Room 109
No. 818, Qiming Road
Ningbo, Zhejiang 315100

Phone : +86.574.8309.9777
Fax : +86.574.8309.9700
Web : www.lansen.com.cn
© 2014 Factset   
Dynamic quotes  
ON
| OFF